Fulgent Genetics Inc
Statements
Cash Flow
Fulgent Genetics Inc (FLGT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.8 | 1.3 | 0.7 | 1.4 | 0.5 | -1.2 | -1.3 | -0.1 | -0.1 | 0.8 | 1.1 | 0.7 | 3.9 | -0.1 | 1.4 | -4.4 | 9.4 | 134 | 233 | 76 | 152 | 77 | 188 | 11 | 21 | 33 | -7.9 | 9.7 | 10 | 15 | 7.3 | 4.3 | -16 | 25 | -4.4 | -30 | 11 | -78 | 7.1 | -24 | -84 | |
| 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.7 | 1.1 | 1.9 | 2.4 | 4.4 | 4.0 | 4.7 | 8.3 | 9.8 | 9.8 | 6.9 | 6.3 | 6.4 | 6.5 | 6.7 | 6.2 | 5.9 | 6.2 | 5.9 | 6.1 | 6.0 | 6.1 | 6.0 | 6.0 | 24 | |
| 2.5 | 0.5 | 0.6 | 0.4 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 1.0 | 0.9 | 0.9 | 1.1 | 3.2 | 3.0 | 3.0 | 3.5 | 4.4 | 5.0 | 5.6 | 8.0 | 9.0 | 10 | 10 | 10 | 11 | 11 | 12 | 12 | 11 | 10 | 11 | 10 | 9.7 | 9.3 | 9.9 | 19 | 47 | |
| – | 10 | 0.5 | 0.6 | 0.7 | 2.8 | 0.5 | 0.9 | 0.5 | 1.9 | 0.8 | 1.0 | 1.1 | 1.3 | 1.3 | 1.3 | 2.9 | 3.2 | 3.5 | 2.1 | 2.5 | 11 | 12 | 16 | 18 | 24 | 4.8 | 5.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.3 | -0.5 | -0.5 | 0.3 | 0.3 | -0.8 | -0.5 | -0.6 | -0.6 | 0.4 | 1.5 | -1.2 | 0.7 | -1.8 | 1.3 | -9.8 | -44 | -39 | 25 | -8.2 | 22 | -42 | 15 | -25 | -11 | 23 | -4.8 | 8.6 | -11 | 10 | 4.9 | -2.6 | -26 | 16 | -9.8 | -39 | 2.4 | -72 | 17 | -16 | -68 | |
| 2.8 | 0.4 | 0.1 | 1.4 | 2.7 | 1.1 | 1.1 | 0.5 | 1.0 | 0.1 | 0.1 | 0.5 | 0.1 | 0.6 | 0.8 | 0.4 | 10 | 24 | 11 | 2.9 | 3.4 | 6.0 | 5.4 | 3.3 | 5.4 | 4.7 | 2.0 | 12 | 4.9 | 3.1 | 4.1 | 13 | 20 | 3.8 | 4.7 | 6.8 | 6.1 | 5.0 | 5.2 | 3.9 | 20 | |
| -2.8 | -39 | -1.9 | 4.2 | -2.6 | -1.8 | 0.1 | -1.5 | 5.0 | -2.5 | -2.5 | 3.2 | 6.3 | -36 | -3.9 | -2.4 | -1.4 | -319 | -216 | -155 | -35 | -140 | 0.7 | -214 | 44 | -93 | -4.4 | -1.1 | 20 | 24 | -47 | 7.3 | 9.0 | -27 | 28 | 53 | 19 | 11 | 11 | 51 | 92 | |
| 0.0 | 4.6 | 4.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | 0.6 | – | – | – | – | – | 0.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | -2.0 | 0.0 | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 0.0 | 0.0 | -0.1 | 0.2 | 0.0 | -0.5 | 0.0 | -2.9 | -0.7 | -0.5 | -11 | -35 | -29 | -0.9 | -0.2 | -2.7 | -24 | -1.9 | -0.5 | -0.4 | -0.2 | -11 | -2.6 | -0.4 | -0.4 | -40 | -24 | -65 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 15 | 15 | 15 | 15 | 0.0 | 0.0 | -0.1 | 0.0 | -0.5 | -0.1 | -0.2 | -0.2 | -16 | -16 | – | – | – | – | -0.1 | -0.1 | -0.6 | -0.1 | -0.1 | -0.1 | -0.6 | -0.1 | -0.8 | |
| -5.8 | 38 | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 28 | -0.2 | -0.1 | 43 | 219 | 47 | 28 | -3.0 | 13 | -0.9 | -11 | -35 | -30 | -1.1 | -16 | -4.5 | -26 | -2.8 | -1.1 | -0.6 | -0.3 | -11 | -2.6 | -0.4 | -0.5 | -45 | -24 | -70 | |
| -7.9 | -0.3 | -1.2 | 4.7 | -2.0 | -3.0 | -1.2 | -1.6 | 4.8 | -1.8 | -1.4 | 3.9 | 11 | -8.6 | -2.7 | -6.9 | 51 | 34 | 64 | -51 | 114 | -50 | 188 | -214 | 30 | -89 | -13 | -7.8 | 26 | 13 | -43 | 10 | -6.9 | -2.9 | 12 | 21 | 30 | -67 | -27 | 2.9 | -62 | |
| -2.0 | 0.8 | 0.6 | -0.1 | -2.2 | -2.4 | -2.4 | -0.6 | -1.2 | 0.7 | 0.9 | 0.2 | 3.8 | -0.7 | 0.6 | -4.8 | -0.7 | 110 | 222 | 73 | 149 | 71 | 183 | 7.9 | 15 | 28 | -9.9 | -2.4 | 5.3 | 12 | 3.2 | -8.7 | -35 | 21 | -9.1 | -37 | 5.1 | -83 | 1.9 | -28 | -104 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.